CONMED Other Long-Term Assets 2010-2024 | CNMD

CONMED other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
CONMED Annual Other Long-Term Assets
(Millions of US $)
2023 $96
2022 $94
2021 $99
2020 $97
2019 $102
2018 $63
2017 $63
2016 $56
2015 $43
2014 $10
2013 $10
2012 $7
2011 $7
2010 $8
2009 $6
CONMED Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $125
2024-06-30 $105
2024-03-31 $108
2023-12-31 $107
2023-09-30 $107
2023-06-30 $109
2023-03-31 $106
2022-12-31 $94
2022-09-30 $100
2022-06-30 $107
2022-03-31 $108
2021-12-31 $99
2021-09-30 $105
2021-06-30 $106
2021-03-31 $101
2020-12-31 $97
2020-09-30 $100
2020-06-30 $98
2020-03-31 $103
2019-12-31 $102
2019-09-30 $91
2019-06-30 $90
2019-03-31 $91
2018-12-31 $63
2018-09-30 $70
2018-06-30 $70
2018-03-31 $70
2017-12-31 $63
2017-09-30 $67
2017-06-30 $65
2017-03-31 $62
2016-12-31 $56
2016-09-30 $15
2016-06-30 $15
2016-03-31 $15
2015-12-31 $43
2015-09-30 $10
2015-06-30 $10
2015-03-31 $10
2014-12-31 $10
2014-09-30 $12
2014-06-30 $12
2014-03-31 $11
2013-12-31 $10
2013-09-30 $9
2013-06-30 $150
2013-03-31 $151
2012-12-31 $7
2012-09-30 $152
2012-06-30 $154
2012-03-31 $153
2011-12-31 $7
2011-09-30 $7
2011-06-30 $7
2011-03-31 $8
2010-12-31 $8
2010-09-30 $5
2010-06-30 $6
2010-03-31 $6
2009-12-31 $6
2009-09-30 $6
2009-06-30 $7
2009-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.215B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49